CANCER-TREATMENT TODAY AND ITS IMPACT ON DRUG DEVELOPMENT, WITH SPECIAL EMPHASIS ON PHASE-2 CLINICAL-TRIAL

被引：41

作者：

CARTER, SK ^{[1
]}

机构：

[1] NCI, DEPT CANC TREATMENT, BETHESDA, MD 20014 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1976年 / 57卷 / 02期

关键词：

D O I：

10.1093/jnci/57.2.235

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：235 / 244

页数：10

共 63 条

AUR, RJA ;

SIMONE, J ;

HUSTU, HO ;

WALTERS, T ;

BORELLA, L ;

PRATT, C ;

PINKEL, D .

BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 37 (03) :272-&

[2]

BAKER LH, 1975, P AM ASSOC CANC RES, V16, P229

[3]

BERTINO JR, 1973, CANCER-AM CANCER SOC, V31, P1141, DOI 10.1002/1097-0142(197305)31:5<1141::AID-CNCR2820310515>3.0.CO

[4]

2-R

[5]

BLOM J, 1975, P AM ASSOC CANC RES, V16, P247

[6]

BONADON G, 1975, P AM ASSOC CANC RES, V16, P254

[7]

BREWER JI, 1970, 6TH P NAT CANC C PHI, P387

[8]

BRODER LE, 1972, PROG EXP TUMOR RES, V17, P373

[9]

BRODER LE, 1974, CANCER TREAT REV, V1, P183, DOI 10.1016/S0305-7372(74)80002-2

[10]

CARBONE P P, 1974, Gynecologic Oncology, V2, P348, DOI 10.1016/0090-8258(74)90025-0